The global retinoids industry is poised for substantial growth, with a current valuation of US$ 1.5 Billion in 2022 and a projected surge to US$ 2.5 Billion by 2032. This growth is anticipated to occur at a steady Compound Annual Growth Rate (CAGR) of 5.4% between 2022 and 2032.
Dermatologists are increasingly favoring less invasive procedures and topical treatments over traditional surgical interventions. As a result, the demand for retinoids, known for their effectiveness in addressing various skin issues, is on the rise. Post-surgery, retinoids play a pivotal role, aligning with the growing preference for natural and organic skincare solutions.
Get Recently Updated Report of Market as Sample Copy: https://www.futuremarketinsights.com/reports/sample/rep-gb-8060
One driving factor behind the escalating demand for retinoids is the surge in cases of acne globally. The market has witnessed a paradigm shift, with manufacturers now incorporating retinoids into a diverse range of products, including moisturizers, wrinkle reducers, sunscreens, nail care products, acne reducers, and nail care creams.
“We are excited to witness the remarkable growth of the global retinoids industry, and Future Market Insights is well-positioned to capitalize on this trend,” said Sabyasachi Ghosh (Associate Vice President at Future Market Insights, Inc.). “Our commitment to providing cutting-edge dermatological solutions aligns perfectly with the industry’s shift towards less invasive treatments and the growing demand for natural skincare products.”
As a leading player in the retinoids market, Future Market Insights continues to invest in research and development to innovate and expand its product portfolio. The company remains dedicated to offering advanced skincare solutions that cater to the evolving preferences of dermatologists and consumers alike.
Key Takeaways from Retinoids Market:
- North America, led by the US, holds more than 30% of the market share. This could be credited to rising incidences of skin disorders and facial acne over here.
- Europe stands second with Germany leading from the front. It holds more than 10% of the market share. This could be reasoned with enhancements in healthcare infrastructure with growing awareness about appropriate skincare regimen and utilization of retinol and various other ingredients in the cosmetic medications and products.
- Coming to the Asia-Pacific, Japan holds more than 9% of the market share; due to an ever-increasing utilization of retinoids in skin care medication and dermatology. Research states that Japan was home to nearly 3,050 general hospitals as of October 2020. Call to look better irrespective of age is driving adoption of the cosmetic products containing good quantity of retinoids for improving level of collagen in the body.
- Synthetic retinoids overpower conventional ones in terms of pharmacological qualities as they pass through specific RAR (retinoic acid receptors), which are capable of reducing side-effects.
Reach Out To Our Analyst And Get All Your Queries Answered: https://www.futuremarketinsights.com/ask-question/rep-gb-8060
Competitive Arena:
- Bausch Health Companies Inc., through its dermatology division “Ortho Dermatologics”, delivered 4 presentations at the Florida Society of Dermatology Physician Assistants (FSDPA). They covered novel clinical data related to SILIQ, DUOBRIL, and JUBLIA injection, along with several encore presentations.
- Differin, the very first consumer acne medication approved by the US FDA and doled out by Galderma Laboratories, L.P., has started getting subjected to an audio and a digital advertising campaign that would translate into strategic partnership with Acast Creative.
- The US FDA, in August 2018, approved once-daily retinoid product termed as “Altreno” floored by Ortho Dermatologics to treat patients aged 9 and above.
What does the Report Cover?
- Future Market Insights offers an exclusive perspective and various real-time insights on the retinoids market in its latest study, presenting historical demand assessment of 2016 – 2021 and projections for 2022 – 2032.
- The research study is based on type (natural retinoids and synthetic retinoids), by application (acne, psoriasis, anti-aging, and likewise), and by distribution channel (hospitals pharmacies, online pharmacies, retail pharmacies, and hypermarkets/supermarkets).
Key Companies Profiled:
- GlaxoSmithKline Inc.
- Mylan Pharmaceuticals Inc.
- Sun Pharmaceutical Industries Ltd.
- Janssen Pharmaceuticals Inc.
- Bausch Health Companies Inc.
- Ortho Dermatologics
Revolutionizing Customer Engagement: Learn from Our Customization Report: https://www.futuremarketinsights.com/customization-available/rep-gb-8060
Key Market Segments Covered in Retinoids Industry Research:
By Type:
- Natural Retinoids
- Synthetic Retinoids
By Application:
- Acne
- Psoriasis
- Anti-aging
- Others
By Distribution Channel:
- Hospitals Pharmacies
- Online Pharmacies
- Retail Pharmacies
- Supermarkets / Hypermarkets
By Region:
- North America
- Latin America
- Europe
- South Asia
- East Asia
- Oceania
- Middle East and Africa (MEA)
About Future Market Insights (FMI)
Future Market Insights, Inc. (ESOMAR certified, recipient of the Stevie Award, and a member of the Greater New York Chamber of Commerce) offers profound insights into the driving factors that are boosting demand in the market. FMI stands as the leading global provider of market intelligence, advisory services, consulting, and events for the Packaging, Food and Beverage, Consumer Technology, Healthcare, Industrial, and Chemicals markets. With a vast team of over 5000 analysts worldwide, FMI provides global, regional, and local expertise on diverse domains and industry trends across more than 110 countries.
Contact Us:
Future Market Insights Inc.
Christiana Corporate, 200 Continental Drive,
Suite 401, Newark, Delaware – 19713, USA
T: +1-845-579-5705
For Sales Enquiries: sales@futuremarketinsights.com
Website: https://www.futuremarketinsights.com
LinkedIn| Twitter| Blogs | YouTube